Cat. No.: DAB-0012378
Product Information | |
---|---|
Clonality | Monoclonal |
Host Species | Rabbit |
Product Description | Monoclonal antibody is produced by immunizing animals with synthetic peptides corresponding to residues surrounding Leu44 of human LC3B (conserved in LC3A), Ala275 of human NRF2, Leu228 of human NQO1, Leu118 of mouse HO-1, and near the carboxy termini of human KEAP1 and SQSTM1/p62 proteins. Phosphorylation-specific monoclonal antibodies are produced by immunizing rabbits with synthetic phosphopeptides corresponding to Ser349 of human SQSTM1/p62 protein. |
Format | Liquid |
Purity | Affinity purity |
Target Information | |
---|---|
Gene Description | The cap ’n’ collar, leucine zipper transcription factor NRF2 ) is the master regulator of the cellular antioxidant response, regulating the expression of over 200 genes that contain antioxidant response elements in their regulatory regions by heterodimerizing with small MAF proteins. While NRF2 is expressed in all cell types, its basal protein levels are usually kept low during homeostatic conditions, mainly by KEAP1., der normal conditions, KEAP1 binds to and targets NRF2 for ubiquitination-dependent proteasomal degradation. Upon oxidative stress, KEAP1 is modified on some sensor cysteines, affecting its conformation and thus interfering its binding to NRF2, allowing newly synthesized NRF2 to accumulate and translocate to the nucleus to activate its target genes, including HO-1 and NQO1 H:quinone oxidoreductase 1). Another mode of NRF2 regulation involves the autophagy adapter protein p62 in a KEAP1-dependent but cysteine-independent manner, the so called non-canonical pathway. Autophagy is a tightly regulated cellular quality control system that removes damaged proteins or organelles. Autophagy can also be activated to degrade macromolecules to provide nutrients under cellular starvation stress. p62, especially upon phosphorylation at Ser349, can compete with NRF2 for binding KEAP1 and, as a result, p62 sequesters KEAP1 into the autophagosome and prevents KEAP1-mediated NRF2 degradation. This process may also require autophagy protein LC3. In addition, studies also found that KEAP1 is a p62-regulated substrate for autophagy-mediated degradation, indicating that p62 also plays a role in controlling KEAP1 turnover. Dysregulation of autophagy results in prolonged NRF2 activation and this may contribute to many diseases, including cancer and neurodegenerative diseases. |
Shipping & Storage | |
---|---|
Shipping | Shipped at 4 °C. |
Storage Instructions | Store at +4 °C short term (1-2 weeks). Store at -20 °C long term. |
Storage Buffer | Constituent: 100% PBS |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.